Centre of Research Excellence in post-market surveillance of medicines and medical devices’

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Medicines & medical devices constitute a significant cost to Australia’s health care system. Adverse events resulting from their use are similarly a significant expense that could be reduced by the development of Australia's capacity to use linked health data-sets to detect & monitor adverse events. This Centre aims to develop capacity, methods, knowledge & tools to enhance post-marketing surveillance systems to improve information on medicine & device safety, effectiveness & utilisation.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2018

Funding Scheme: Centres of Research Excellence

Funding Amount: $2,500,001.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse drug reactions | adverse events | joint replacement | monitoring | pharmacoepidemiology | policy evaluation | prosthesis | surveillance